This page lists the SEC filings reported by Meditor Group Ltd.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2012-07-26 | Meditor Group Ltd | VIVUS INC | 4,611,600 | 4.6% | EDGAR |
| SC 13G/A | 2012-05-03 | Meditor Group Ltd | VIVUS INC | 4,593,100 | 4.7% | EDGAR |
| SC 13G/A | 2012-03-21 | Meditor Group Ltd | VIVUS INC | 6,177,500 | 6.3% | EDGAR |
| SC 13G | 2012-02-24 | Meditor Group Ltd | VIVUS INC | 4,881,000 | 5.5% | EDGAR |
| SC 13G | 2008-03-28 | Meditor Group Ltd | VION PHARMACEUTICALS INC | 271,940 | 3.4% | EDGAR |
| SC 13G | 2008-03-18 | Meditor Group Ltd | VION PHARMACEUTICALS INC | 420,270 | 5.2% | EDGAR |
| SC 13G | 2008-02-15 | Meditor Group Ltd | VION PHARMACEUTICALS INC | 5,736,200 | 7.6% | EDGAR |
| SC 13G | 2008-02-05 | Meditor Group Ltd | VION PHARMACEUTICALS INC | 5,866,200 | 7.8% | EDGAR |
| SC 13G | 2008-01-18 | Meditor Group Ltd | VION PHARMACEUTICALS INC | 5,866,200 | 7.8% | EDGAR |
| SC 13G | 2007-09-26 | Meditor Group Ltd | CYPRESS BIOSCIENCE INC | 1,864,645 | 5.0% | EDGAR |
| SC 13G | 2007-09-12 | Meditor Group Ltd | ONYX PHARMACEUTICALS INC | 2,627,800 | 4.8% | EDGAR |
| SC 13G | 2007-09-12 | Meditor Group Ltd | CYPRESS BIOSCIENCE INC | 1,897,845 | 5.1% | EDGAR |
| SC 13G | 2007-09-07 | Meditor Group Ltd | ONYX PHARMACEUTICALS INC | 3,168,800 | 5.8% | EDGAR |
| SC 13G | 2007-08-16 | Meditor Group Ltd | ONYX PHARMACEUTICALS INC | 3,792,800 | 6.9% | EDGAR |
| SC 13G | 2007-07-27 | Meditor Group Ltd | ONYX PHARMACEUTICALS INC | 4,239,400 | 7.8% | EDGAR |
| SC 13G | 2007-07-26 | Meditor Group Ltd | ACUSPHERE INC | 1,839,421 | 4.0% | EDGAR |
| SC 13G | 2007-07-13 | Meditor Group Ltd | ACUSPHERE INC | 2,639,421 | 5.7% | EDGAR |
| SC 13G | 2007-07-03 | Meditor Group Ltd | ACUSPHERE INC | 2,831,221 | 6.1% | EDGAR |
| SC 13G | 2007-07-03 | Meditor Group Ltd | ONYX PHARMACEUTICALS INC | 4,752,400 | 8.7% | EDGAR |
| SC 13G | 2007-06-25 | Meditor Group Ltd | ONYX PHARMACEUTICALS INC | 4,730,400 | 8.7% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.